Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-05-15, Stock:JNJ, The news for the past five days is as follows:
2018-05-08: NEWS1: FDA Approves JNJ’s Darzalex in Combination with VMP.NEWS2: Celgene’s Otezla Witnessed Solid Growth in 1Q18.NEWS3: Analyzing Merck’s Revenue in 1Q18.NEWS4: 5 Dividend Aristocrats Where Analysts See Capital Gains.NEWS5: 5 Dividend Aristocrats Where Analysts See Capital Gains.NEWS6: Celgene’s Pomalyst Saw 24% Growth in 1Q18 Compared to 1Q17.NEWS7: A Look at Biogen’s Cash Flows and Price Performance.NEWS8: How Much Upside Do Anaysts Expect for Biogen Stock?.NEWS9: How Amgen’s Aranesp, Epogen and Sensipar Did in 1Q18.NEWS10: Benzinga's Daily Biotech Pulse: Valeant Earnings, Lipocine's FDA Watch, Invivo CFO Departure.NEWS11: It's Raining FDA Approvals, MSON Muscling Up, RDHL To Report Data In Aug..NEWS12: It's Raining FDA Approvals, MSON Muscling Up, RDHL To Report Data In Aug..
2018-05-09: NEWS1: Johnson & Johnson Stock Looks Attractive on the Big Dip.NEWS2: Theravance Biopharma (TBPH) Q1 Loss Narrows, Sales Up Y/Y.NEWS3: Theravance Biopharma (TBPH) Q1 Loss Narrows, Sales Up Y/Y.NEWS4: How Did Regeneron’s Eylea, Kevzara, and Zaltrap Perform in 1Q18?.NEWS5: Theravance Biopharma (TBPH) Q1 Loss Narrows, Sales Up Y/Y.NEWS6: Merck’s Immunology and Cardiovascular Products in 1Q18.NEWS7: Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for May 10, 2018.NEWS8: Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for May 10, 2018.NEWS9: A Overview of Merck’s Diabetes Products in 1Q18.NEWS10: See what the IHS Markit Score report has to say about Johnson & Johnson..
2018-05-10: NEWS1: How Much Upside Potential Does Celgene Offer?.NEWS2: MARKETS: Biotech and pharma stocks could be the key to the market bull case.NEWS3: MARKETS: US stocks post gains, oil drops on profit-taking, Nvidia and Dropbox earnings in focus.NEWS4: What’s AbbVie’s Business Strategy for 2018?.NEWS5: How Much Upside Do Analysts Expect from AbbVie?.NEWS6: VIVUS (VVUS) Q1 Loss Narrower Than Expected, Qsymia Falters.NEWS7: VIVUS (VVUS) Q1 Loss Narrower Than Expected, Qsymia Falters.NEWS8: Dow turns positive for 2018 for first time in more than 3 weeks as benchmark rises nearly 200 points.NEWS9: Local company raises $11.2 million from investors including VSP Global, J&J, Nikon.NEWS10: Dow's 140-point late-morning climb puts it on the verge of turning positive for 2018.NEWS11: Designing Chips Internally Could Be a Drain on Facebook’s Profits.NEWS12: Analysts’ Recommendations for Merck, Post-1Q18 Results.NEWS13: VIVUS (VVUS) Q1 Loss Narrower Than Expected, Qsymia Falters.NEWS14: The Dow is flirting with a break in to positive territory for 2018 for the first time in a month.NEWS15: Johnson & Johnson Stock Looks Attractive on the Big Dip.NEWS16: Johnson & Johnson Stock Looks Attractive on the Big Dip.
2018-05-11: NEWS1: An Ear To The Pharma: 8 Stocks To Watch (VYGR, BOLD, RXII, CYADâ€¦).NEWS2: An Ear To The Pharma: 8 Stocks To Watch (VYGR, BOLD, RXII, CYADâ€¦).NEWS3: Should You Buy Johnson & Johnson (NYSE:JNJ) Now?.NEWS4: Geron (GERN) Q1 Loss Narrows Y/Y, Revenues Fall, Shares Down.NEWS5: Geron (GERN) Q1 Loss Narrows Y/Y, Revenues Fall, Shares Down.NEWS6: Merck vs. Pfizer: Which Stock Looks Better Post Q1 Earnings?.NEWS7: Merck vs. Pfizer: Which Stock Looks Better Post Q1 Earnings?.NEWS8: Pharma Stock Roundup: LLY to Buy Cancer Biotech, J&J, AZN, Roche Announce Updates.NEWS9: Pharma Stock Roundup: LLY to Buy Cancer Biotech, J&J, AZN, Roche Announce Updates.NEWS10: Trump to announce ways to lower prescription drug costs.NEWS11: Geron (GERN) Q1 Loss Narrows Y/Y, Revenues Fall, Shares Down.NEWS12: Pharma Stock Roundup: LLY to Buy Cancer Biotech, J&J, AZN, Roche Announce Updates.
2018-05-14: NEWS1: J&J defends itself in trial over baby powder asbestos claims.NEWS2: Johnson & Johnson defends itself in trial over baby powder asbestos claims.NEWS3: J&J defends itself in trial over baby powder asbestos claims.NEWS4: Falcone Says Benevir Transaction Indicative of Portfolio's Value.NEWS5: Analyst: Morphosys Is Well-Positioned To Continue Success With Antibody Discovery Platforms.NEWS6: The Trump Plan To Reduce Prescription Drug Prices Will Have A Major Impact.NEWS7: How Much Upside Does Bristol-Myers Squibb Offer?.NEWS8: QUAL, JNJ, SCHW, BLK: Large Inflows Detected at ETF.NEWS9: QUAL, JNJ, SCHW, BLK: Large Inflows Detected at ETF.NEWS10: The Math Shows XRLV Can Go To $38.NEWS11: The Math Shows XRLV Can Go To $38.NEWS12: Big banks say their legal costs are tumbling.

Answer: Decrease